Leuconostoc and application thereof
According to the leuconostoc strain and the application thereof, the leuconostoc strain HX-236 is obtained through self-screening, the HX-236 takes cordyceps militaris powder as a sole nitrogen source, fermentation filtrate can be obtained through fermentation culture, the content of cordycepin and cordycepic acid in the fermentation filtrate is high, and the fermentation filtrate is easy to dissolve in water, convenient to use, good in stability and good in compatibility; the expression of hypoxia-inducible factors (HIF-1alpha) in cells can be remarkably improved, so that signal channels for downstream regulation of inflammatory response, cell autophagy and tissue neogenesis are activated, and then the problems of skin aging such as cell viability decline, collagen loss, hyperpigmentation and skin elasticity reduction caused by hypoxia are solved by regulating the hypoxia pressure of the cells; wide application prospects are realized in the fields of medicines, cosmetics and the like..
| Medienart: |
|
|---|
Patent| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Europäisches Patentamt - (2023) vom: 28. Juli Zur Gesamtaufnahme - year:2023 |
|---|
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
SUN SHAOJING [VerfasserIn] |
|---|
| Links: |
Volltext [kostenfrei] |
|---|
| Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-07-28, Last update posted on www.tib.eu: 2023-12-05, Last updated: 2023-12-08 |
|---|
| Patentnummer: |
CN116496926 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
EPA018274528 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | EPA018274528 | ||
| 003 | DE-627 | ||
| 005 | 20231208120216.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231020s2023 xx |||||o 00| ||eng c | ||
| 035 | |a (DE-627)EPA018274528 | ||
| 035 | |a (EPA)CN116496926 | ||
| 035 | |a (EPA)87317241 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a SUN SHAOJING |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Leuconostoc and application thereof |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Source: www.epo.org (no modifications made), First posted: 2023-07-28, Last update posted on www.tib.eu: 2023-12-05, Last updated: 2023-12-08 | ||
| 520 | |a According to the leuconostoc strain and the application thereof, the leuconostoc strain HX-236 is obtained through self-screening, the HX-236 takes cordyceps militaris powder as a sole nitrogen source, fermentation filtrate can be obtained through fermentation culture, the content of cordycepin and cordycepic acid in the fermentation filtrate is high, and the fermentation filtrate is easy to dissolve in water, convenient to use, good in stability and good in compatibility; the expression of hypoxia-inducible factors (HIF-1alpha) in cells can be remarkably improved, so that signal channels for downstream regulation of inflammatory response, cell autophagy and tissue neogenesis are activated, and then the problems of skin aging such as cell viability decline, collagen loss, hyperpigmentation and skin elasticity reduction caused by hypoxia are solved by regulating the hypoxia pressure of the cells; wide application prospects are realized in the fields of medicines, cosmetics and the like. | ||
| 650 | 4 | |a bio | |
| 650 | 4 | |a C12P: Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture | |
| 650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
| 650 | 4 | |a C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000) | |
| 650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
| 650 | 4 | |a che | |
| 650 | 4 | |a C12R: Indexing scheme associated with subclasses c12c-c12q, relating to microorganisms | |
| 650 | 4 | |a A61Q: Specific use of cosmetics or similar toilet preparations | |
| 650 | 4 | |a 615 | |
| 700 | 0 | |a JIN YAN |4 aut | |
| 700 | 0 | |a WEN LIANGLIANG |4 aut | |
| 700 | 0 | |a MA LIANG |4 aut | |
| 700 | 0 | |a LU ZHEN |4 aut | |
| 700 | 0 | |a WANG RUIYAN |4 aut | |
| 700 | 0 | |a WANG ENXU |4 aut | |
| 700 | 0 | |a ZHOU XIANLONG |4 aut | |
| 700 | 0 | |a GUO XUEPING |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 28. Juli |
| 773 | 1 | 8 | |g year:2023 |g day:28 |g month:07 |
| 856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/87317241/publication/CN116496926A1?q=CN116496926 |z kostenfrei |3 Volltext |
| 912 | |a GBV_EPA | ||
| 936 | u | w | |j 2023 |b 28 |c 07 |
| 951 | |a AR | ||
| 952 | |j 2023 |b 28 |c 07 | ||